Caudal Dexmetedomedine Versus Magnesium in Orthopedic Pediatric Surgeries
Status:
Unknown status
Trial end date:
2018-03-15
Target enrollment:
Participant gender:
Summary
This study will be performed in Abo Elreesh Pediatric Hospital / Cairo University after
obtaining approval by the University Ethics Committee, and a written informed consent from
the parents or guardians.
Thirty six patients will be randomly assigned using an online randomization program
(http://www.randomizer.org) and the sealed envelope method into three groups: Group D (n=12):
Dexmetedomidine group. 0.5 ml of dexmetedomidine (2 μg/kg) added to bupivacaine, Group M
(n=12) : Magnesium group.0.5 ml of magnesium sulphate (50 mg) added to bupivacaine, Group C
(n=12) :Control group.bupivacaine 0.25% diluted in normal saline with total volume of 1
ml/kg.